What medications are safe for treating migraines during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Migraine Management During Pregnancy

Paracetamol (acetaminophen) is the first-line medication for acute treatment of migraine during pregnancy, with a recommended dose of 1000 mg. 1

Acute Treatment Options

  • Paracetamol (acetaminophen) is the safest and most recommended first-line treatment for migraine attacks during pregnancy, preferably as a 1000 mg dose 1, 2
  • For nausea associated with migraine, metoclopramide can be used, particularly in the second and third trimesters 1, 3
  • NSAIDs such as ibuprofen may be used as second-line options, but only during the second trimester and should be avoided in the first and third trimesters due to specific risks 1, 4
  • When other treatments fail, sumatriptan may be used sporadically under strict specialist supervision, as it has the most safety data among triptans 1, 5
  • Prochlorperazine can be considered for treatment of migraine-associated nausea as it is unlikely to be harmful during pregnancy 2

Preventive Treatment

  • Non-pharmacological approaches should always be tried first before considering preventive medications during pregnancy 1, 4
  • Preventive medications should only be considered in cases of frequent (≥3 per month) and disabling migraine attacks that are unresponsive to acute treatments 1, 3
  • Propranolol has the best available safety data and is the first choice for preventive therapy when needed 1, 6
  • Amitriptyline can be used as an alternative if propranolol is contraindicated 1, 3
  • Topiramate, candesartan, and sodium valproate are contraindicated due to their adverse effects on the fetus 1
  • CGRP antagonists (gepants) and ergot alkaloids have insufficient safety data in pregnancy and should be avoided 1

Non-Pharmacological Approaches

  • Lifestyle modifications should be the initial focus of migraine management during pregnancy 1, 5
  • Staying well hydrated, maintaining regular meals, ensuring sufficient sleep, and engaging in regular physical activity are important non-pharmacological strategies 1
  • Relaxation techniques, massage, ice packs, and biofeedback should be tried before resorting to medications 2, 4
  • Identifying and avoiding personal migraine triggers is crucial for effective management 1

Important Clinical Considerations

  • Migraine often improves during pregnancy, with 60-70% of women experiencing remission or significant improvement, particularly during the second and third trimesters 6, 5
  • Women with migraine onset at menarche and those with perimenstrual migraine are more likely to experience improvement during pregnancy 6
  • Opioids and butalbital should be avoided for treating acute migraine during pregnancy due to associated risks 1
  • Medication overuse headache can occur with frequent use of acute medications (≥15 days/month with NSAIDs; ≥10 days/month with triptans) 1
  • Regular monitoring is essential when medications are used during pregnancy, especially for preventive treatments 1

Post-Partum Period

  • Paracetamol remains the preferred acute medication during breastfeeding 1
  • Ibuprofen and sumatriptan are considered safe options during breastfeeding 1
  • Propranolol is recommended if preventive medication is required postpartum 1
  • Many women experience a recurrence of migraines postpartum, likely due to the drop in estradiol and endorphin levels 5

References

Guideline

Migraine Management During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Migraine therapy during pregnancy and lactation.

Expert opinion on drug safety, 2010

Research

Migraine in pregnancy.

Neurology, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.